(Q36535110)

14 August 2017

1 reference

title

Uveitis: management (English)

1 reference

14 August 2017

1 reference

S. Lightman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683928

28 October 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

14 August 2017

14 December 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1683928

full work available at URL

28 October 2022

https://api.elsevier.com/content/article/PII:014067369192310X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

https://api.elsevier.com/content/article/PII:014067369192310X?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

1 reference

14 August 2017

volume

338

1 reference

14 August 2017

issue

8781

1 reference

14 August 2017

page(s)

1501-1504

1 reference

Low dose cyclosporin A therapy in chronic posterior uveitis

14 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Leucocyte movement and colchicine treatment in Behcet's disease

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Cyclosporin A in the treatment of severe Behçet's uveitis

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Chlorambucil in Behçet's disease. A reappraisal

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Effectiveness of cyclosporin therapy for Behçet's disease

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

A controlled trial of azathioprine in Behçet's syndrome

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

S antigen-induced experimental autoimmune uveo-retinitis in rats

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Anti-Ia antibody diminishes ocular inflammation in experimental autoimmune uveitis

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Prevention of experimental autoimmune uveoretinitis by active immunization with autoantigen-specific monoclonal antibodies.

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

Induction of tolerance in peripheral T cells with monoclonal antibodies.

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)92310-X

28 October 2022

Identifiers

1 reference

14 August 2017

1 reference